Summary & Overview
CPT 85732: Partial Thromboplastin Time (PTT) Laboratory Test
CPT code 85732 denotes a laboratory-performed partial thromboplastin time (PTT) test, a core coagulation assay that measures plasma clotting time after mixing with a specific test plasma fraction. The PTT is widely used in clinical care to evaluate bleeding disorders, monitor unfractionated heparin therapy, and investigate coagulation abnormalities; its prevalence in inpatient and outpatient laboratory workflows makes this code clinically and operationally important nationwide. Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for CPT code 85732, comparisons of payer coverage approaches, typical site-of-service considerations for laboratory processing, and highlights of billing practice elements such as commonly reported modifiers and related service lines. The summary outlines national implications for laboratory utilization and coding consistency, helping laboratory managers, billing staff, and compliance officers understand how CPT code 85732 is applied across care settings and payers. Data not available in the input are noted where applicable.
Billing Code Overview
CPT code 85732 describes a partial thromboplastin time (PTT) test performed by a laboratory analyst, in which the laboratory measures the time it takes for a patient’s plasma sample to clot after mixing the specimen with a specific test plasma fraction. This service evaluates the intrinsic and common coagulation pathways and is used to assess coagulation disorders, monitor heparin therapy, and investigate unexplained bleeding or thrombotic events.
Service Type: Laboratory diagnostic test — coagulation study
Typical Site of Service: Clinical laboratory or hospital laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical adult inpatient or outpatient clinical scenario involves a patient who requires evaluation of intrinsic and common pathway coagulation function. For example, a 58-year-old male admitted for sepsis with elevated bleeding risk, or a 42-year-old female on unfractionated heparin infusion after venous thromboembolism, has a venous blood specimen sent to the laboratory for a partial thromboplastin time test. The workflow begins with the clinician ordering 85732 in the electronic health record with the indication (monitoring anticoagulation, bleeding evaluation, preoperative assessment). A phlebotomist collects a citrated plasma sample, which is transported to the clinical laboratory. A laboratory technologist performs the PTT assay by mixing patient plasma with specific test plasma fraction and activating reagents, measures clot formation time, documents the result in seconds, and reports it to the requesting provider. Results guide decisions such as heparin dose adjustment, further coagulation testing (e.g., factor assays), or perioperative planning. Typical sites of service include hospital inpatient laboratories, outpatient hospital-based laboratories, and independent clinical laboratories associated with ambulatory clinics or anticoagulation clinics.
Coding Specifications
- The following modifiers are most clinically relevant to
85732and reflect common billing scenarios. Use of a modifier must follow payer-specific rules.
| Modifier | Description | When to Use |
|---|---|---|